Watch Ticker

Roivant Sciences Ltd. Common Shares

Go to Roivant Sciences Ltd. Common Shares Website

$11.51

0.00 (0.00%)

Live

Previous Close

$11.51

Day Range

$0 - $0

Previous Day Range

$11.225 - $11.52

Market Cap

$7.7 billion USD

Day Vol.

Previous Day Vol.

3.1 million

Currency

USD

Primary Exchange

Nasdaq

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical busi...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Eric Volkman - Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.

Moderna's stock has been struggling since the end of the COVID-19 pandemic, with a Wall Street analyst cutting her price target and reiterating a sell recommendation. The analyst cited issues such as cost-management struggles and legal headaches, as well as a hold on a late-stage trial for a norovirus vaccine candidate.

Related tickers: MRNA, ROIV, ABUS.

Read Full Article

Globe Newswire - Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

Organon has completed the acquisition of Dermavant Sciences, a company dedicated to developing and commercializing innovative therapeutic solutions in immuno-dermatology, including the FDA-approved VTAMA® (tapinarof) cream for the treatment of plaque psoriasis.

Related tickers: OGN, ROIV.

Read Full Article

Trending Tickers

Please sign in to view